Current through Register Vol. 35, No. 6, March 26, 2024
A facility with two (2) or more residents that is licensed
pursuant to this rule and that assists with self-administration or safeguards
medications for residents shall have a current custodial drug permit issued by
the state board of pharmacy.
A.
Procurement, labeling and storage. The facility shall provide assistance
to the resident in obtaining the necessary medications, treatment and medical
supplies as identified in the ISP. The facility shall procure, label and store
medications for residents who require assistance with self-administration of
medication in compliance with state and federal laws.
(1) All medications, including
non-prescription drugs, shall be stored in a locked compartment or in a locked
room, as approved by the board of pharmacy and the key shall be in the care of
the administrator or designee.
(2)
Internal medication shall be kept separate from external medications. Drugs to
be taken by mouth shall be separated from all other delivery forms.
(3) A separate, locked refrigerator shall be
provided by the facility for medications. The refrigerator temperature shall be
kept in compliance with the state board of pharmacy requirements for
medications.
(4) All medications,
including non-prescription medications, shall be stored in separate
compartments for each resident and all medications shall be labeled with the
resident's name.
(5) A resident may
be permitted to keep his or her own medication in a locked compartment in his
or her room for self-administration, if the physician's order deems it
appropriate.
(6) The facility shall
not require the residents to purchase medications from any particular
pharmacy.
(7) Medical gases
(oxygen) and equipment used for the administration of inhalation therapy and
for resuscitative purposes shall comply with the national fire protection
association (NFPA) 99.
(8) A proof
of use record shall be maintained separately for each schedule II through IV
drug (controlled substances). The proof of use sheet shall document:
(a) the type and strength of the schedule II
through IV drugs;
(b) the date and
time staff assisted with self-administration;
(c) the resident's name;
(d) the prescriber's name;
(e) the dose;
(f) the signature of the person assisting
with delivery of the medication; and
(g) the balance of medication
remaining.
(9) Any
remaining medication discontinued by a physician's order, or upon discharge or
death of the resident shall be inventoried and moved to a separate locked
storage container. Such discontinued medications shall be destroyed upon the
next quarterly visit by the consulting pharmacist in accordance with
16.19.11.10 NMAC.
(10) The record
of medication destruction shall be signed by the administrator or designee and
the pharmacist and shall be kept on file at the facility.
B.
Consulting pharmacist. The
facility shall maintain records demonstrating that the consulting pharmacist
provides the following oversight and guidance.
(1) Reviews the medication regimen as needed,
but at least quarterly/every three (3) months, to determine that all
medications and records are accurate and current. All irregularities shall be
reported to the administrator of the facility and these irregularities shall be
resolved by the administrator within seventy-two (72) hours.
(2) A system of records of receipt and
disposition of all drugs in sufficient detail to enable an accurate
reconciliation.
(3) Consultation
shall be provided on all aspects of pharmacy services in the facility,
including reference information regarding side effects and, when needed,
physician consultation in cases involving the use of psychotropic
medications.
(4) The consulting
pharmacist will be responsible for assuring that the facility meets all
requirements for storage, labeling, destruction and documentation of
medications as required by the state board of pharmacy, 16.19.11.10 NMAC and
7.8.2 NMAC.